A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

This study has been completed.

Study NCT00140049 Information provided by Pfizer

First Received: August 29, 2005 Last Updated: November 29, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2006
Estimated Primary Completion Date:	No date given